Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis

Cytokine

Volumn 48, Issue 3, 2009, Pages 170-176

  Reddy, Aramati B M ^a   Srivastava, Satish K ^a   Ramana, Kota V ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aldose reductase; Cecum ligation and puncture; Cytokines; Inflammation; Sepsis

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; SORBINIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG MECHANISM; ENZYME INHIBITION; HEART; KIDNEY; MALE; MOUSE; NONHUMAN; PERITONEAL FLUID LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; SPLEEN; TISSUE LEVEL;

ALDEHYDE REDUCTASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMIDAZOLIDINES; MICE; MICE, INBRED BALB C; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BACTERIA (MICROORGANISMS); MURINAE; MUS;

EID: 70350023106     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.07.004     Document Type: Article

References (35)

1. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 (2003) 138-150
2. Brown K., Brain S., Pearson J., Edgeworth J., Lewis S., and Treacher D. Neutrophils in development of multiple organ failure in sepsis. Lancet 368 (2006) 157-169
3. Cho S., Minn Y., and Kwon K. Stroke after burn. Cerebrovasc Dis 24 (2007) 261-263
4. Parrillo J.E., Parker M.M., Natanson C., Suffredini A.F., Danner R.L., Cunnion R.E., et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113 (1990) 227-242
5. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
6. Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med 328 (1993) 1471-1478
7. Kurahashi K., Kajikawa O., Sawa T., Ohra M., Gropper M.A., Frank D.W., et al. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 104 (1999) 743-750
8. Eichacker P.Q., Parent C., Kalil A., Esposito C., Cui X., Banks S.M., et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 166 (2002) 1197-1205
9. Ramana K.V., Willis M.S., White M.D., Horton J.W., DiMaio J.M., Srivastava D., et al. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 24 (2006) 1838-1846
10. Ramana K.V., Chandra D., Srivastava S., Bhatnagar A., Aggarwal B.B., and Srivastava S.K. Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J Biol Chem 277 (2002) 32063-32070
11. Ramana K.V., Friedrich B., Srivastava S., Bhatnagar A., and Srivastava S.K. Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 53 (2004) 910-920
12. Ramana K.V., Fadl A.A., Tammali R., Reddy A.B., Chopra A.K., and Srivastava S.K. Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages. J Biol Chem 281 (2006) 33019-33029
13. Ramana K.V., and Srivastava S.K. Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages. Cytokine 36 (2006) 115-122
14. Ramana K.V., Bhatnagar A., Srivastava S., Yadav U.C., Awasthi S., Awasthi Y.C., et al. Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J Biol Chem 281 (2006) 17652-17660
15. Ramana K.V., Reddy A.B., Tammali R., and Srivastava S.K. Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages. Free Radic Biol Med 42 (2007) 1290-1302
16. Bruno S., Cattaneo D., Perico N., and Remuzzi G. Emerging drugs for diabetic nephropathy. Expert Opin Emerg Drugs 10 (2005) 747-771
17. Hamada Y., and Nakamura J. Clinical potential of Aldose reductase inhibitors in diabetic neuropathy. Treat Endocrinol 3 (2004) 245-255
18. Srivastava S.K., Ramana K.V., and Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 26 (2005) 380-392
19. Walley K.R., Lukacs N.W., Standiford T.J., Strieter R.M., and Kunkel S.L. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 64 (1996) 4733-4738
20. Mann D.L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91 (2002) 988-998
21. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
22. Levi M., van der Poll T., ten Cate H., and Van Deventer S.J.H. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxemia. Eur J Clin Invest 27 (1997) 3-9
23. Benjamin C.F., Hogaboam C.M., and Kunkel S.L. The chronic consequences of severe sepsis. J Leukoc Biol 75 (2004) 408-412
24. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and duidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 101 (1992) 1644-1655
25. Maier S., Traeger T., Entleutner M., Westerholt A., Kleist B., Huser N., et al. Cecal ligation and puncture versus colon ascendens stent peritonitis: two distinct animal models for polymicrobial sepsis. Shock 21 (2004) 505-511
26. Hubbard W.J., Choudhry M., Schwacha M.G., Kerby J.D., Rue III L.W., Bland K.I., et al. Cecal ligation and puncture. Shock 24 (2005) 52-57
27. Wang P., and Chaudry I.H. A single hit model of polymicrobial sepsis: cecal ligation and puncture. Sepsis 2 (1998) 227-233
28. Damas P., Ledoux D., Nys M., Vrindts Y., De Groote D., Franchimont P., et al. Cytokine serum level during sepsis in human IL-6 as a marker of severity. Ann Surg 215 (1992) 356-362
29. Ho E., and Bray T.M. Antioxidants, NF-κB activation, and diabetogenesis. Proc Soc Exp Biol Med 222 (1999) 205-213
30. Ramnath R.D., Ng S.W., Guglielmotti A., and Bhatia M. Role of MCP-1 in endotoxemia and sepsis. Int Immunopharmacol 8 (2008) 810-818
31. Yang S., Hu S., Hsieh Y., Choudhry M.A., RueIII L.W., Balnd K.I., et al. Mechanism of IL-6-mediated cardiac dysfunction following trauma-hemorrhage. J Mol Cell Cardiol 40 (2006) 570-579
32. Ritter C., Andrades M.E., Reinke A., Menna-Barreto S., Moreira J.F., and Dal-Pizzol F. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med 32 (2004) 342-349
33. Galley H.F., Howdle P.D., Walker B.E., and Webster N.R. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med 23 (1997) 768-774
34. Spapen H., Zhang H., Demanet C., Vleminckx W., Vincent J.L., and Huyghens L. Does N-acetyl-l-cysteine influence cytokine response during early human septic shock?. Chest 113 (1998) 1616-1624
35. Konukoglu D., Iynem H., and Ziylan E. Antioxidant status in experimental peritonitis: effects of alpha tocopherol and taurolin. Pharmacol Res 39 (1999) 247-251